Crossmark

Pathological complete response in a patient with metastatic pancreatic acinar cell carcinoma who received a chemotherapy regimen containing cisplatin and irinotecan

Crossref DOI link: https://doi.org/10.1007/s12328-021-01518-z

Published Online: 2021-10-01

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maehira, Hiromitsu https://orcid.org/0000-0003-3064-5216
Iida, Hiroya

Mori, Haruki

Nitta, Nobuhito

Tokuda, Aya

Takebayashi, Katsushi

Kaida, Sachiko

Miyake, Toru

Matsubara, Akiko

Tani, Masaji
License Information

Text and Data Mining valid from 2021-10-01

Version of Record valid from 2021-10-01
More Information

Article History

Received: 16 August 2021

Accepted: 7 September 2021

First Online: 1 October 2021

Declarations

:

: Hiromitsu Maehira, Hiroya Iida, Haruki Mori, Nobuhito Nitta, Aya Tokuda, Katsushi Takebayashi, Sachiko Kaida, Toru Miyake, Akiko Matsubara, and Masaji Tani declare that they have no conflict of interest.

: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: Not applicable.

: Informed consent was obtained from all patients for being included in the study.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Document is current

Any future updates will be listed below